SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending following a triple earnings beat and a guidance raise that has sparked intense speculation regarding a potential massive short squeeze, given that over 40% of the float is currently sold short. Investors are cheering the company's strong revenue growth and enterprise AI deal momentum, with many community members debating whether the stock's double-digit move signals a sustained rally or a temporary pump.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is facing significant volatility as investors brace for the expiration of a major lock-up period, which releases nearly one billion insider shares into the public float. The community remains deeply divided, with some investors betting on a sharp short-term sell-off while others view the pullback as a long-term entry opportunity, fueled by debates over the company's aggressive AI and infrastructure expansion plans.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

Ripple's XRP is currently trending as the community debates the stalled progress of the Clarity Act and its potential impact on institutional adoption. Investors are heavily divided between bullish sentiment regarding the token's long-term utility in global settlements and bearish frustration over ongoing price stagnation and concerns about supply dilution.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending as investors react to the finalized SkyWater Technology acquisition, while the community remains divided over its long-term valuation and high cash burn versus its growth potential and expanding government partnerships. Analysts are closely watching upcoming earnings for clarity on how this vertical integration and the company's backlog will impact their future commercial trajectory.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy is facing significant selling pressure after reporting disappointing quarterly margins and project delivery delays that prompted a cut to annual guidance. Despite long-term optimism surrounding the company's record backlog and potential hyperscaler partnerships, the community is actively debating whether the margin contraction is a temporary accounting timing issue or a signal of a broken business model.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending as investors react to positive regulatory progress on its mRNA-based influenza vaccine and active institutional accumulation ahead of key pipeline updates. Community discussions remain polarized, balancing enthusiasm for the company's oncology and rare disease pipeline against ongoing debates regarding the long-term commercial potential of its mRNA platform.

Investment Managers Series Trust II - Tradr 2X Short SNDK Daily ETF

Tradr 2X Short SNDK Daily ETF

Tradr 2X Short SNDK Daily ETF (SNDQ) is experiencing significant volatility and trading volume as market participants debate whether the semiconductor sector is entering a major correction after a period of intense speculative growth. Community sentiment is deeply polarized, with active discussion focusing on using this leveraged instrument to hedge against potential valuation crashes in memory chip leaders, while many warn of the risks associated with daily volatility decay.

Honeywell Aerospace, Inc. engages in the provision of aerospace and defense critical systems and technologies. It operates through the following segments: Electronic Solutions, Engines & Power Systems, and Control Systems. The Electronic Solutions segment supplies aerospace electronic systems and technologies such as avionics and navigation sensors and electromagnetic defensive solutions. The Engine & Power Systems segment manufactures propulsion systems, APUs, and electric power solutions. The Control Systems segment handles the supply of thermal and motion control systems that enable flight, life support, and safety for the aircraft. The company was founded in 1914 and is headquartered in Phoenix, AZ.

Honeywell Aerospace Inc

Honeywell Aerospace

Honeywell Aerospace ($HONA) is trending due to a volatile post-earnings sell-off, as investors weigh management's lowered short-term guidance against a strong, record-breaking order backlog. While some traders are exiting due to supply chain frustrations and fiscal caution, long-term investors are debating whether the dip represents a temporary friction point or a prime entry opportunity into a essential aerospace player.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital is facing intense selling pressure despite reporting earnings that beat expectations, with the market focusing on concerns over NAND pricing and softer-than-expected forward guidance. Investors are actively debating whether this is a structural peak for the memory sector or a temporary opportunity to accumulate shares of a company central to AI storage demand.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending due to a major earnings beat and a significant increase to its share buyback program, though shares are facing volatility as investors weigh the impressive quarterly performance against cooling sequential growth projections. The community remains deeply divided, with bulls pointing to long-term memory supply agreements and AI infrastructure demand as reasons to buy the dip, while bears argue that the stock is overvalued and susceptible to cyclical headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMPACT Platform

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMPACT Platform Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMPACT Platform PR Newswire CAMBRIDGE, Mass., Aug. 3, 2026 Portfolio now...

Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV Platform into High Consequence Global Health Threats

Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV Platform into High Consequence Global Health Threats Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV Platform into High Consequence Global Health Threats...

Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors

Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors PR Newswire CAMBRIDGE, Mass., July 15, 2026 CAMBRIDGE, Mass., July 15, 2026 /PRNewswire/ -- Decoy Therapeutics Inc. (Nasdaq: DCOY), a...

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers

Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 284.8% to $11.39 during Monday's regular session. The company's market cap stands at $1.9 million.
Decoy Therapeutics (NASDAQ:DCOY) sharesread more...

DCOY Stock Nearly Doubled In Value Today – What’s Driving This Mega Rally?

Equity

Decoy Therapeutics has secured funding to begin clinical trials for its programs targeting respiratory illnesses.


Decoy Therapeutics Secures Milestone-Based Financing to Advance Antiviral Pipeline

Decoy Therapeutics (NASDAQ:DCOY) announced a private investment in public equity (PIPE) financing that could provide the biotechnology company with up to approximately $21 million in gross proceeds through a combination of upfront funding and milestone-based warrant exercises. The initial closing is expected to generate approximately $3.5 million, with additional capital becoming available if specified clinical, regulatory, and shareholder approval milestones are achieved. The company said it intends to use the proceeds to advance its lead antiviral candidate into clinical trials.

4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones

As the second half of 2026 begins, a series of regulatory approvals, strategic acquisitions, clinical development milestones, and financing initiatives are highlighting continued activity across the biotechnology and healthcare sectors, as companies work to expand pipelines, strengthen balance sheets, and advance toward commercialization. $UPC, $NTHI, $DCOY, $VRDN

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers

Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 159.6% to $7.68 during Monday's pre-market session. The company's market cap stands at $1.9 million.
Decoy Therapeutics (NASDAQ:DCOY) stockread more...

Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing

Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing PR Newswire HOUSTON, June 26, 2026 HOUSTON, June 26, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (NASDAQ: DCOY) (the "Company" or...

Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London

Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London PR Newswire CAMBRIDGE, Mass., June 8, 2026 Rick Pierce to join speakers from Boehringer Ingelheim, RA Capital and ILiAD Biotechnologies for...

Decoy Therapeutics, Inc. operates as a preclinical-stage biotechnology company. It engages in leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company was founded by Frederick E. Pierce, Barbara Hibner, Peter Marschel, Michael Lipp, and Jodi Cooper in 2020 and is headquartered in Houston, TX.

Decoy Therapeutics Inc.

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$4.19
Prev Close	$4.37
Open	$4.20
Dividend Yield	0.00%
50-Day Moving Average	$6.10
Beta	0.18
Avg. Volume	83,741.14
PE Ratio	-0.03

52-Week High	$106.20
52-Week Low	$3.51
Market Capitalization	$2.58M
EPS (Annual)	-$129.10
Price to Book	0.57
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info